News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Tibb F. Jacobs, PharmD, BCPS

Articles by Tibb F. Jacobs, PharmD, BCPS

Incretin Mimetics: Pros and Cons, and Emerging Agents in Diabetes Treatment

ByJamie M. Terrell, PharmD,Tibb F. Jacobs, PharmD, BCPS

December 14th 2013

Drug Pipeline

Latest Updated Articles

Incretin Mimetics: Pros and Cons, and Emerging Agents in Diabetes Treatment
Published: December 14th 2013 | Updated:

Trending on AJMC

Breast Cancer Dominating Oncology Research, Access Disparities: Gen Li, PhD

Nearly All US Youth With BMI-Defined Obesity Have Excess Adiposity

Role of MRAs in Heart Failure Treatment

GLP-1 for Treatment of Heart Failure

Supporting Patients on Oral Breast Cancer Therapies: Michael Hassett, MD, MPH

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.